1. Home
  2. CPRX vs KNTK Comparison

CPRX vs KNTK Comparison

Compare CPRX & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • KNTK
  • Stock Information
  • Founded
  • CPRX 2002
  • KNTK 2017
  • Country
  • CPRX United States
  • KNTK United States
  • Employees
  • CPRX N/A
  • KNTK N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • KNTK Natural Gas Distribution
  • Sector
  • CPRX Health Care
  • KNTK Utilities
  • Exchange
  • CPRX Nasdaq
  • KNTK Nasdaq
  • Market Cap
  • CPRX 2.6B
  • KNTK 2.8B
  • IPO Year
  • CPRX 2006
  • KNTK N/A
  • Fundamental
  • Price
  • CPRX $21.29
  • KNTK $39.44
  • Analyst Decision
  • CPRX Strong Buy
  • KNTK Buy
  • Analyst Count
  • CPRX 5
  • KNTK 10
  • Target Price
  • CPRX $33.20
  • KNTK $53.20
  • AVG Volume (30 Days)
  • CPRX 1.4M
  • KNTK 1.3M
  • Earning Date
  • CPRX 11-05-2025
  • KNTK 11-05-2025
  • Dividend Yield
  • CPRX N/A
  • KNTK 7.73%
  • EPS Growth
  • CPRX 183.96
  • KNTK N/A
  • EPS
  • CPRX 1.65
  • KNTK 0.73
  • Revenue
  • CPRX $558,499,000.00
  • KNTK $1,652,079,000.00
  • Revenue This Year
  • CPRX $16.59
  • KNTK $30.28
  • Revenue Next Year
  • CPRX $8.80
  • KNTK $14.29
  • P/E Ratio
  • CPRX $12.72
  • KNTK $55.00
  • Revenue Growth
  • CPRX 28.55
  • KNTK 19.71
  • 52 Week Low
  • CPRX $19.05
  • KNTK $35.74
  • 52 Week High
  • CPRX $26.58
  • KNTK $67.60
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 57.67
  • KNTK 50.10
  • Support Level
  • CPRX $20.66
  • KNTK $35.79
  • Resistance Level
  • CPRX $21.55
  • KNTK $41.23
  • Average True Range (ATR)
  • CPRX 0.57
  • KNTK 1.50
  • MACD
  • CPRX 0.05
  • KNTK 0.43
  • Stochastic Oscillator
  • CPRX 84.24
  • KNTK 67.10

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).

About KNTK Kinetik Holdings Inc.

Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.

Share on Social Networks: